GSK has made a new drug submission (NDS) to Health Canada for the monoclonal ant...
WHO member states convened in Geneva despite the absence of the organisation’s l...
Lupin has signed a licence and supply agreement with SteinCares to commercialise...
The US FDA has accepted for review Otsuka Pharmaceutical’s biologics licence app...
Upperton Pharma Solutions is a winner in the Business Expansion category in the ...
The EMA has validated the MAA submitted by Soleno Therapeutics for diazoxide cho...
Biogen and City Therapeutics are set to partner for the development of new RNA i...
Cell and gene therapy (C>) is set to revolutionise treatment of complex diseas...
The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as ...
The 12th Outsourcing in Clinical Trials UK & Ireland conference will focus on th...
The China NMPA's CDE has granted breakthrough therapy designation approval to Ab...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detec...
Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year a...
Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at alm...
Genentech has announced an investment exceeding $700m to establish its first Eas...
